A Little Girl’s Battle with Hutchinson-Gilford Progeria Syndrome

Full Article PDF Review History

Published: 2023-09-13

Page: 451-454

Sadia Akram

Department of Surgery, Farooq Hospital, West Wood Branch, Lahore, Pakistan.

Zunaira Muzzamil *

Department of Surgery, Farooq Hospital, West Wood Branch, Lahore, Pakistan.

Zufishan Muzzamil

Department of Surgery, Farooq Hospital, West Wood Branch, Lahore, Pakistan.

Iram Muzzamil

University of Education, Township Branch, Lahore, Pakistan.

*Author to whom correspondence should be addressed.


I have presented here a very strange and rare case of a six years old girl, Kaitlyn, who has already faced more challenges in her short life than most people encounter in a decade. She is suffering from Hutchinson-Gilford Progeria Syndrome (HGPS) which is a rare genetic condition that causes accelerated aging and a shortened life expectancy. HGPS progressively causes the body to stop functioning. Symptoms typically develop in early childhood and can include rapid muscle growth, extreme thinness, and problems with bone density. Progeria is a very slow-moving disease and there is no cure. Fortunately, my patient Kaitlyn is now doing well and is able to speak and walk. She also loves going to school and spending time with her family and friends. Her biggest challenge is managing her energy and staying healthy. She's currently in a clinical trial for a new treatment that has the potential to stop or even reverse the progression of HGPS.

Keywords: Hutchinson-gilford progeria, muscle growth, bone density

How to Cite

Akram, S., Muzzamil, Z., Muzzamil, Z., & Muzzamil, I. (2023). A Little Girl’s Battle with Hutchinson-Gilford Progeria Syndrome. Asian Journal of Case Reports in Surgery, 6(2), 451–454. Retrieved from https://journalajcrs.com/index.php/AJCRS/article/view/450


Download data is not yet available.


De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003;300(5628):2055.

DOI: 10.1126/science.1084125 [PubMed] Access on 2003 Apr 17

Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423(6937):293-8.

DOI: 10.1038/nature01629. [PubMed] Access on 2003 Apr 25

Hennekam RC. Hutchinson-Gilford progeria syndrome: Review of the phenotype. Am J Med Genet A. 2006;140(23):2603-24. DOI: 10.1002/ajmg.a.31346 [PubMed]

Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R, Collins FS. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2004;101(24):8963-8.

DOI: 10.1073/pnas.0402943101. Access on 2004 Jun 7

Halaschek-Wiener J, Brooks-Wilson A. Progeria of stem cells: Stem cell exhaustion in Hutchinson-Gilford progeria syndrome. J Gerontol A Biol Sci Med Sci. 2007;62(1):3-8. DOI: 10.1093/gerona/62.1.3. [PubMed]

Badame AJ. Progeria. Arch Dermatol. 1989;125:540–4. [PubMed] [Google Scholar]

Liag L, Zhang H, Gu X. Homozygous LMNA mutation R527C in atypical Hutchinson-Gilford progeria syndrome: Evidence for autosomal recessive inheritance. Acta Paediatr. 2009;98:1315–8. [PubMed] [Google Scholar] [Ref list]

Gordon LB, Massaro J, D’Agostino RB Sr, Campbell SE, Brazier J, Brown WT, et al. Progeria Clinical Trials Collaborative. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation. 2014;130:27–34. [PMC free article] [PubMed] [Google Scholar]

Varela I, Pereira S, Ugalde AP, Navarro CL, Suárez MF, Cau P, et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med. 2008;14:767–72. [PubMed] [Google Scholar]